HARRY MOORE, M.D.
Medical Oncology Physician · MACON, GA
Individual Active NPI 1699096388
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,601 | 332,879 | $20,015,589 | $7,879,922 | $6,281,993 |
| 2023 | 1,553 | 275,584 | $12,964,523 | $5,672,531 | $4,514,377 |
| 2022 | 1,529 | 257,433 | $12,374,140 | $5,766,684 | $4,608,969 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 31,201 | $56 | $45 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 28,500 | $1 | $1 |
| J9025 | Injection, azacitidine, 1 mg | 19,436 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 17,860 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 17,800 | $30 | $24 |
| J1453 | Injection, fosaprepitant, 1 mg | 17,550 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 13,860 | $49 | $39 |
| J0897 | Injection, denosumab, 1 mg | 12,660 | $25 | $20 |
| J9267 | Injection, paclitaxel, 1 mg | 11,364 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8,331 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 7,020 | $2 | $1 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 5,950 | $27 | $22 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 69071 | GA |
| Specialist | 174400000X | — | GA | |
| Internal Medicine Physician | 207R00000X | 4288 | GA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Georgia
- NPI 1679689301
- NPI 1396772117
- NPI 1801000260
- NPI 1528177623
- NPI 1346357019
- NPI 1740032374
- NPI 1497045553
- NPI 1831262922
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.